Julie E. Mangino
- Infectious Diseases top 0.5%
- Epidemiology top 2%
- Molecular Medicine top 1%
- Pharmacology top 2%
- Applied Microbiology and Biotechnology top 0.2%
- Co-authors
- Debra A. GoffPeter G. PappasRobert A. LarsenHarold W. HorowitzJohn RexCarol A. KauffmanRichard J. HamillWilliam G. Powderly
- Topics
- Antibiotic Use and Resistance (17 papers)Nosocomial Infections in ICU (15 papers)Clostridium difficile and Clostridium perfringens research (14 papers)
- Journals
- SHILAP Revista de lepidopterologíaClinical Infectious DiseasesCHEST Journal
- Partner nations
- United StatesSouth AfricaCanada
In The Last Decade
Julie E. Mangino
65 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Infectious Diseases 1.7k
- Epidemiology 1.6k
- Molecular Medicine 489
- Pharmacology 450
- Applied Microbiology and Biotechnology 441
Countries citing papers authored by Julie E. Mangino
This map shows the geographic impact of Julie E. Mangino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie E. Mangino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie E. Mangino more than expected).
Fields of papers citing papers by Julie E. Mangino
This network shows the impact of papers produced by Julie E. Mangino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie E. Mangino. The network helps show where Julie E. Mangino may publish in the future.
Co-authorship network of co-authors of Julie E. Mangino
This figure shows the co-authorship network connecting the top 25 collaborators of Julie E. Mangino. A scholar is included among the top collaborators of Julie E. Mangino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie E. Mangino. Julie E. Mangino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 6 | |
| 3 | 47 | |
| 4 | 35 | |
| 5 | 53 | |
| 6 | 5 | |
| 7 | 20 | |
| 8 | 30 | |
| 9 | 7 | |
| 10 | 34 | |
| 11 | 4 | |
| 12 | 30 | |
| 13 | 56 | |
| 14 | 79 | |
| 15 | 24 | |
| 16 | 9 | |
| 17 | Outcomes in Patients with MRSA Bacteremia and Reduced Susceptibility to Vancomycin | 1 |
| 18 | A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patientsbreakdown → | 666 |
| 19 | 38 | |
| 20 | 7 |
About Julie E. Mangino
Julie E. Mangino is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Molecular Medicine, having authored 66 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (17 papers), Nosocomial Infections in ICU (15 papers) and Clostridium difficile and Clostridium perfringens research (14 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (441 citations), Molecular Medicine (489 citations) and Infectious Diseases (1.7k citations). Julie E. Mangino has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Debra A. Goff, Peter G. Pappas, Robert A. Larsen, Harold W. Horowitz, John Rex, Carol A. Kauffman, Richard J. Hamill, William G. Powderly, Karri A. Bauer and Preeti Pancholi. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.